MAP2 | Microtubule-associated protein 2 | FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
MBP | Myelin basic protein | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Tissue enriched |
MOBP | Myelin-associated oligodendrocyte basic protein | | | | | | Tissue enriched |
MOG | Myelin oligodendrocyte glycoprotein | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
MT3 | Metallothionein 3 | | | | | | Tissue enriched |
NAPB | N-ethylmaleimide-sensitive factor attachment protein, beta | | | | | | Tissue enriched |
NECAB1 | N-terminal EF-hand calcium binding protein 1 | | | | | | Tissue enriched |
NPTXR | Neuronal pentraxin receptor | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
NR2E1 | Nuclear receptor subfamily 2, group E, member 1 | Nuclear receptors Transcription factors
| | | | | Tissue enriched |
NRGN | Neurogranin (protein kinase C substrate, RC3) | | | | | | Tissue enriched |
NSF | N-ethylmaleimide-sensitive factor | Enzymes Transporters
| | | | | Tissue enriched |
OLIG2 | Oligodendrocyte lineage transcription factor 2 | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enriched |
OPALIN | Oligodendrocytic myelin paranodal and inner loop protein | Predicted membrane proteins
| | | | | Tissue enriched |
P2RY12 | Purinergic receptor P2Y, G-protein coupled, 12 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
PACSIN1 | Protein kinase C and casein kinase substrate in neurons 1 | Plasma proteins
| | | | | Tissue enriched |
PEX5L | Peroxisomal biogenesis factor 5-like | | | | | | Tissue enriched |
PGM2L1 | Phosphoglucomutase 2-like 1 | Enzymes
| | | | | Tissue enriched |
PLP1 | Proteolipid protein 1 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
PRKCG | Protein kinase C, gamma | Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Tissue enriched |
RAB3A | RAB3A, member RAS oncogene family | | | | | | Tissue enriched |
RPH3A | Rabphilin 3A homolog (mouse) | | | | | | Tissue enriched |
RTN1 | Reticulon 1 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
SCG3 | Secretogranin III | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SEPT3 | Septin 3 | | | | | | Tissue enriched |
SERPINI1 | Serpin peptidase inhibitor, clade I (neuroserpin), member 1 | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
SH3GL2 | SH3-domain GRB2-like 2 | | | | | | Tissue enriched |
SHISA7 | Shisa family member 7 | Predicted membrane proteins
| | | | | Tissue enriched |
SLC17A6 | Solute carrier family 17 (vesicular glutamate transporter), member 6 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC17A7 | Solute carrier family 17 (vesicular glutamate transporter), member 7 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC1A2 | Solute carrier family 1 (glial high affinity glutamate transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC1A3 | Solute carrier family 1 (glial high affinity glutamate transporter), member 3 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC32A1 | Solute carrier family 32 (GABA vesicular transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC35F1 | Solute carrier family 35, member F1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC8A2 | Solute carrier family 8 (sodium/calcium exchanger), member 2 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SMIM18 | Small integral membrane protein 18 | Predicted membrane proteins
| | | | | Tissue enriched |
SNAP25 | Synaptosomal-associated protein, 25kDa | FDA approved drug targets Transporters
| | | | | Tissue enriched |
SNCB | Synuclein, beta | | | | | | Tissue enriched |
ST8SIA3 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 | Predicted membrane proteins
| | | | | Tissue enriched |
STXBP1 | Syntaxin binding protein 1 | Disease related genes Plasma proteins
| | | | | Tissue enriched |
SULT4A1 | Sulfotransferase family 4A, member 1 | | | | | | Tissue enriched |
SV2A | Synaptic vesicle glycoprotein 2A | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
SYN1 | Synapsin I | Disease related genes Plasma proteins
| | | | | Tissue enriched |
SYP | Synaptophysin | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SYT1 | Synaptotagmin I | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SYT11 | Synaptotagmin XI | | | | | | Tissue enriched |
TAGLN3 | Transgelin 3 | Plasma proteins
| | | | | Tissue enriched |
TMEM88B | Transmembrane protein 88B | Predicted membrane proteins
| | | | | Tissue enriched |
TNR | Tenascin R | Predicted secreted proteins
| | | | | Tissue enriched |
TPPP | Tubulin polymerization promoting protein | | | | | | Tissue enriched |